一项评价淋巴示踪用盐酸米托蒽醌注射液用于胃癌
患者淋巴示踪的单盲、单中心、安全性、耐受性、药代动力学特征及初步疗效的剂量递增和剂量扩展的I期/IIa 期临床试验研究
[Translation] A single-blind, single-center, dose-escalation and dose-expansion clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer.
本试验的目的是探索淋巴示踪用盐酸米托蒽醌注射液对胃癌患者淋巴示踪的有效性、安全性和耐受性并确定试验用药物最优使用剂量范围,同时探索淋巴示踪用盐酸米托蒽醌注射液对胃癌患者的药代动力学特征,为III 期临床试验的用
药剂量及评价指标提供合理依据。
[Translation] The purpose of this trial is to explore the efficacy, safety and tolerability of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer and determine the optimal dosage range of the trial drug. At the same time, it is to explore the pharmacokinetic characteristics of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer, and to provide a reasonable basis for the dosage and evaluation indicators of the Phase III clinical trial.
淋巴示踪用盐酸米托蒽醌注射液用于乳腺癌手术前哨淋巴结示踪的有效性和安全性的多中心、阳性、自身对照临床
[Translation] A multicenter, positive, self-controlled clinical trial of the efficacy and safety of mitoxantrone hydrochloride injection for sentinel lymph node tracing before breast cancer surgery
评价试验药物对乳腺癌受试者前哨淋巴结示踪的有效性与安全性。
[Translation] To evaluate the effectiveness and safety of investigational drugs in sentinel lymph node tracing in subjects with breast cancer.
MMT注射液用于乳腺癌淋巴示踪的单中心、阳性、自身对照I期临床试验
[Translation] A single-center, positive, self-controlled phase I clinical trial of MMT injection for lymph node tracing in breast cancer
本试验的目的是评价MMT注射液对乳腺癌患者淋巴结示踪的安全性和探索试验用药物最优使用剂量与使用方法及有效性。
[Translation] The purpose of this trial is to evaluate the safety of MMT injection in lymph node tracing in patients with breast cancer and to explore the optimal dosage, method of use and effectiveness of the trial drug.
100 Clinical Results associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.